卵形疟原虫非洲分离株K13基因的多态性分析

doi:10.12140/j.issn.1000-7423.2019.02.009

中国寄生虫学与寄生虫病杂志 ›› 2019, Vol. 37 ›› Issue (2): 167-172.doi: 10.12140/j.issn.1000-7423.2019.02.009

卵形疟原虫非洲分离株K13基因的多态性分析

陈静¹(), 刘耀宝¹, 唐凤¹, 陆凤^1,², 唐建霞^1,^3,^*(), 曹俊¹

1 国家卫生计生委寄生虫病预防与控制技术重点实验室,江苏省寄生虫与媒介控制技术重点实验室,世界卫生组织消除疟疾研究与培训合作中心,江苏省寄生虫病防治研究所,无锡 214064
2 扬州大学医学院,扬州 225000
3 江南大学公共卫生研究中心,无锡 214000

收稿日期:2018-09-04 出版日期:2019-04-30 发布日期:2019-05-13
通讯作者: 唐建霞
作者简介:
作者简介：陈静（1992-）,女,硕士研究生,从事病原生物学研究。E-mail：2460826456@qq.com
基金资助:
国家重点研发计划专项（No. 2016YFC1200500）;国家自然科学基金（No. 81601790）;江苏省自然科学基金（No. BK20150001）;江苏省重点研发计划（No. BE2016631）;江南大学公共卫生研究中心项目（No. GWZX201505）;江苏省公益类科研院所能力提升项目（No. BM2015024）;江苏省“科教强卫工程”项目

Polymorphism analysis of K13 gene of Plasmodium ovale isolates from Africa

Jing CHEN¹(), Yao-bao LIU¹, Feng TANG¹, Feng LU^1,², Jian-xia TANG^1,^3,^*(), Jun CAO¹

1 Key Laboratory of National Health and Family Planning Commission on Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, WHO Collaborating Centre for Research and Training on Malaria Elimination, Jiangsu Institute of Parasitic Diseases, Wuxi 214064, China
2 Medical College, Yangzhou University, Yangzhou 225000, China
3 Jiangnan University Public Health Research Center, Wuxi 214000,China

Received:2018-09-04 Online:2019-04-30 Published:2019-05-13
Contact: Jian-xia TANG
Supported by:
Supported by the National Key Research and Development Program of China(No. 2016YFC1200500);National Natural Science Foundation of China(No. 81601790);Natural Science Foundation of Jiangsu Province(No. BK20150001);Jiangsu Provincial Key Research and Development Program (No. BE2016631);Public Health Research Center project, Jiangnan University(No. GWZX201505);Jiangsu Public Welfare Research Institute Capacity Enhancement Project(No. BM2015024);Jiangsu Provincial Project of Invigorating Health Care through Science, Technology and Education

摘要/Abstract

摘要：

目的分析卵形疟原虫柯氏亚种（Plasmodium ovale curtisi）和沃氏亚种（P. ovale wallikeri）非洲分离株K13蛋白编码基因的多态性,为卵形疟原虫青蒿素抗性监测提供科学依据。方法收集江苏省2012-2016年卵形疟患者血样,经流行病学调查确认为非洲输入性卵形疟病例。提取血样DNA,通过实时荧光PCR探针法鉴别卵形疟原虫柯氏亚种和沃氏亚种。采用巢式PCR扩增K13基因的结构域并送测序,以卵形疟原虫柯氏亚种参考序列（PlasmoDB登录号：PocGH01_12019400）和沃氏亚种参考序列（GenBank登录号：LT594516.1）为模板,应用BioEdit软件对测序序列进行比对,应用DNAstar软件分析序列的突变情况,用DnaSP软件分析序列多态性,用MEGA软件构建系统进化树。结果 2012-2016年共收集168例卵形疟患者的血样,感染来源地为中非（95例）、南非（37例）、西非（34例）、东非（1例）和北非（1例）;卵形疟原虫柯氏亚种和沃氏亚种各84例。168例血样K13基因巢式PCR均扩增获得1 500 bp的条带且均测序成功。卵形疟原虫K13基因核苷酸多样性指数π为0.000 02,单体型多样性指数Hd为0.024,2个亚种K13基因分别含有2个单体型,分别发现1个单核苷酸多态性位点,各有1例样本检出卵形疟原虫核苷酸碱基突变,柯氏亚种在核苷酸717 bp（氨基酸239E）位点处存在A/G突变,沃氏亚种在核苷酸1998 bp（氨基酸666P）位点处存在T/A突变,均为同义突变,与卵形疟原虫青蒿素耐药性无关。本研究患者血样卵形疟原虫2个亚种K13基因序列中性检验统计结果无明显差异,符合中性进化模型。系统进化树显示,卵形疟原虫柯氏亚种2个单体型聚为一支,沃氏亚种2个单体型聚为另一支。结论卵形疟原虫非洲分离株柯氏亚种和沃氏亚种K13基因未发现非同义突变,其基因多态性水平较低,无青蒿素耐药性相关的基因突变。

关键词: 卵形疟原虫, K13基因, 青蒿素抗性, 基因多态性

Abstract:

Objective To analyze the polymorphism of the K13 protein-encoding gene of Plasmodium ovale curtisi and wallikeri isolates from Africa so as to provide molecular basis for monitoring artemisinin resistance of P. ovale in Africa. Methods The blood samples were collected from imported malaria patients with P. ovale identified by microscopic and epidemiological investigation from 2012 to 2016 in Jiangsu Province. DNA was extracted from the blood samples and the P. ovale K13 gene was amplified by nested PCR. The subspecies of P. ovale were further determined by Real-time TaqMan^R PCR. The acquired DNA sequences were aligned with reference sequences from P. ovale curtisi subspecies (PlasmoDB: PocGH01_12019400) and the wallikeri subspecies (GenBank: LT594516.1) using BioEdit software. The mutations of the obtained DNA sequences were analyzed using DNAstar software. The polymorphism of K13 gene was analyzed by DnaSP software. The phylogenetic tree was constructed using MEGA software. Results A total of 168 P. ovale infected blood samples were collected from malaria patients during 2012-2016 in Jiangsu Province. It was confirmed that the sources of infection were from Central African (95 cases), South Africa (37 cases), West Africa (34 cases) and one case from East and North Africa. A 1 500 bp fragment of K13 gene was successfully amplified from all samples and sequenced. The sequence results identified that half of the samples were P. ovale curtisi subspecies (84) or wallikeri subspecies (84). The nucleotide diversity index π of P. ovale K13 gene was 0.000 02. The haplotype diversity index Hd was 0.024. The K13 genes of two subspecies contained two haplotypes and one single nucleotide polymorphism site. There is only one nucleotide polymorphism within each P. ovale subspecies. The P. ovale curtisi had a A/G polymorphism at nucleotide 717 (amino acid 239E) and the P. ovale wallikeri had a T/A polymorphism at the nucleotide 1998 (amino acid 666P), both of them were synonymous mutations without the change of encoded amino acids. The two mutations identified in this study are not related to P. ovale artemisinin resistance. Neutral test was performed on the DNA sequences of both subspecies of P. ovale without statistical difference. The mutation in P. ovale K13 gene in this study is in accordance with the neutral evolution model. The phylogenetic tree shows that the two haplotypes of P. ovale curtisi subspecies are clustered into one branch, and the two haplotypes of P. ovale wallikeri subspecies are clustered into another branch. Conclusion No nonsynonymous mutation is found in K13 gene of P. ovale curtisi and wallikeri subspecies in this study. K13 gene has a low level of genetic polymorphism in Africa isolations and no mutation is related to P. ovale artemisinin resistance.

Key words: Plasmodium ovale, K13 gene, Artemisinin resistance, Genetic polymorphism

中图分类号:

R382.319

陈静, 刘耀宝, 唐凤, 陆凤, 唐建霞, 曹俊. 卵形疟原虫非洲分离株K13基因的多态性分析[J]. 中国寄生虫学与寄生虫病杂志, 2019, 37(2): 167-172.

Jing CHEN, Yao-bao LIU, Feng TANG, Feng LU, Jian-xia TANG, Jun CAO. Polymorphism analysis of K13 gene of Plasmodium ovale isolates from Africa[J]. Chinese Journal of Parasitology and Parasitic Diseases, 2019, 37(2): 167-172.

图/表 5

图1

表1

图2

表2

图3

参考文献 26

[1]	Stephens JWW.A new malaria parasite of man[J]. Ann Trop Med Parasitol, 1922, 16(4): 383-388.
[2]	Sutherland CJ, Tanomsing N, Nolder D, et al. Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally[J]. J Infect Dis, 2010, 201(10): 1544-1550.
[3]	Nakeesathit S, Saralamba N, Pukrittayakamee S, et al. Limited polymorphism of the Kelch propeller domain in Plasmodium malariae and P. ovale isolates from Thailand[J]. Antimicrob Agents Chemother, 2016, 60(7): 4055-4062.
[4]	Mayxay M, Pukrittayakamee S, Newton PN, et al. Mixed-species malaria infections in humans[J]. Trends Parasitol, 2004, 20(5): 233-240.
[5]	Imwong M, Nakeesathit S, Day NP, et al. A review of mixed malaria species infections in anopheline mosquitoes[J]. Malar J, 2011, 10: 253.
[6]	Noedl H, Se Y, Schaecher K, et al. Evidence of artemisinin-resistant malaria in western Cambodia[J]. N Engl J Med, 2008, 359(24): 2619-2620.
[7]	Phyo AP, Nkomo S, Stepniewska K, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study[J]. Lancet, 2012, 379(9830): 1960-1966.
[8]	Ashley EA, Dhorda M, Fairhurst RM, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria[J]. N Engl J Med, 2014, 371(5): 411-423.
[9]	Kyaw MP, Nyunt MH, Chit K, et al. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar[J]. PLoS One, 2013, 8(3): e57689.
[10]	Ariey F, Witkowski B, Amaratunga C, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria[J]. Nature, 2014, 505(7481): 50-55.
[11]	Ghorbal M, Gorman M, Macpherson CR, et al. Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system[J]. Nat Biotechnol, 2014, 32(8): 819-821.
[12]	Takala-Harrison S, Jacob CG, Arze C, et al. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia[J]. J Infect Dis, 2015, 211(5): 670-679.
[13]	White NJ.Malaria: a molecular marker of artemisinin resistance[J]. Lancet, 2014, 383(9927): 1439-1440.
[14]	Mbengue A, Bhattacharjee S, Pandharkar T, et al. A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria[J]. Nature, 2015, 520(7549): 683-687.
[15]	Lu F, Culleton R, Zhang M, et al. Emergence of indigenous artemisinin-resistant Plasmodium falciparum in Africa[J]. N Engl J Med, 2017, 376(10): 991-993.
[16]	Talundzic E, Ndiaye YD, Deme AB, et al. Molecular epidemiology of Plasmodium falciparum kelch13 mutations in senegal determined by using targeted amplicon deep sequencing[J]. Antimicrob Agents Chemother, 2017, 61(3): e02116-16.
[17]	Xu C, Wei Q, Yin K, et al. Surveillance of antimalarial resistance Pfcrt, Pfmdr1, and Pfkelch13 polymorphisms in African Plasmodium falciparum imported to Shandong Province, China[J]. Sci Rep, 2018, 8(1): 12951.
[18]	Li X, Zhang D, Hannink M, et al. Crystal structure of the Kelch domain of human Keap1[J]. J Biol Chem, 2004, 279(52): 54750-54758.
[19]	Bauffe F, Desplans J, Fraisier C, Parzy D.Real-time PCR assay for discrimination of Plasmodium ovale curtisi and Plasmodium ovale wallikeri in the Ivory Coast and in the Comoros Islands[J]. Malar J, 2012, 11: 307.
[20]	Ariey F, Witkowski B, Amaratunga C, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria[J]. Nature, 2014, 505(7481): 50-55.
[21]	罗飞, 周爽, 袁熠, 等. 2011-2015年重庆市境外输入性疟疾流行特征分析及防控策略探讨[J].中国血吸虫病防治杂志, 2017, 29(3): 310-314.
[22]	毛祥华, 邓艳, 董莹,等. 云南省输入性疟疾病例时间分布特征分析[J]. 中国血吸虫病防治杂志, 2017, 29(4): 445-448.
[23]	张丽, 丰俊, 张少森, 等. 2017年全国消除疟疾进展及疫情特征分析[J].中国寄生虫学与寄生虫病杂志, 2018, 36(3): 201-209.
[24]	Maltha J, Gillet P, Jacobs J.Malaria rapid diagnostic tests in travel medicine[J]. Clin Microbiol Infect, 2013, 19(5): 408-415.
[25]	World Health Organization.Emergency response to artemisinin resistance in the Greater Mekong subregion: Regional FrameWork for Action 2013-2015[R]. Geneva: World Health Organization, 2013.
[26]	World Health Organization.Artemisinin and artemisinin-based combination therapy resistance[R]. Geneva: World Health Organization, 2017.

感染来源 Origin of infection	柯氏亚种数量 No. of P. ovale curtisi	沃氏亚种数量 No. of P. ovale wallikeri	合计 Total
南非South Africa
安哥拉Angola	10	22	32
莫桑比克Mozambique	1	2	3
南非共和国 The Republic of South Africa	1	0	1
赞比亚Zambia	1	0	1
小计Subtotal	13	24	37
西非West Africa
几内亚Guinea	1	3	4
加纳Ghana	1	1	2
科特迪瓦Cote d'Ivoire	0	1	1
利比里亚Liberia	2	1	3
尼日尔Niger	1	0	1
尼日利亚Nigeria	13	8	21
萨拉里昂Sierra Leone	1	1	2
小计Subtotal	19	15	34
中非 Central Africa
赤道几内亚Equatorial Guinea	31	26	57
刚果（布）Republic of Congo	7	7	14
刚果（金）Democratic Republic of the Congo	7	2	9
加蓬Gabon	1	4	5
喀麦隆Cameroon	6	4	10
小计Subtotal	52	43	95
东非 East Africa
乌干达Uganda	0	1	1
小计Subtotal	0	1	1
北非 North Africa
南苏丹South Sudan	0	1	1
小计Subtotal	0	1	1
合计Total	84	84	168

亚种Subspecies	样本数 No. of samples	单体型数 No. of haplotypes	核苷酸多样性指数π	单体型多样性指数Hd	单核苷酸多态性SNP	非同义突变数 No. of non-synonymous mutation	同义突变数No. of synonymous mutation	Tajima’s D检验 Tajima’s D test	Fu-Li 检验 Fu-Li’s test	Fay-Wu 检验 Fay-Wu test
柯氏亚种P. ovale curtisi	84	2	0.000 02	0.024	1	0	1	-1.047 26	-1.985 58	-1.984 24
沃氏亚种P. ovale wallikeri	84	2	0.000 02	0.024	1	0	1	-1.047 26	-1.985 58	-1.984 24

卵形疟原虫非洲分离株K13基因的多态性分析

Polymorphism analysis of K13 gene of Plasmodium ovale isolates from Africa

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 5

参考文献 26

相关文章 15

编辑推荐

Metrics

本文评价

[1]	于嘉利, 刘蕾, 杨博, 楚瑞林, 孙毅凡, 刘耀宝, 程洋. 重组卵形疟原虫裂殖子表面蛋白1 N端的抗原性及免疫原性分析[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(6): 746-752.
[2]	张耀光, 江莉, 王真瑜, 朱民, 朱倩, 马晓疆, 吴寰宇. 上海市2例输入性卵形疟误诊病例的实验室诊断分析[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(4): 553-556.
[3]	尚婧晔, 张光葭, 喻文杰, 何伟, 廖沙, 李汭芮, 黄燕, 刘阳, 钟波. 多房棘球绦虫遗传多态性研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(5): 637-641.
[4]	金行一, 张玲玲, 朱素娟, 徐卫民, 陈珺芳, 阮卫, 姚立农, 陈华良. 间日疟原虫裂殖子表面蛋白1和环子孢子蛋白基因多态性分析[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(3): 323-331.
[5]	魏玉环, 刘华, 李武军, 赵海, 胡媛, 曹建平. 西藏阿里地区细粒棘球蚴人体分离株nad1基因多态性分析[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(1): 17-22.
[6]	杨成运, 李素华, 张雅兰, 周瑞敏, 刘颖, 钱丹, 赵玉玲, 许汴利, 张红卫, 邓艳. 河南省输入性恶性疟原虫多药抗性基因1和K13基因的突变分析[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(2): 97-102.
[7]	张玲玲, 姚立农, 陈华良, 陆巧绎, 阮卫. 输入性卵形疟原虫细胞色素b、细胞色素c氧化酶Ⅰ和乳酸脱氢酶基因单核苷酸多态性分析[J]. 中国寄生虫学与寄生虫病杂志, 2017, 35(5): 429-433.
[8]	董莹, 孙艾明, 邓艳, 陈梦妮, 徐艳春, 毛祥华. 云南省恶性疟原虫氯喹及青蒿素抗性相关基因的联合突变分析[J]. 中国寄生虫学与寄生虫病杂志, 2017, 35(3): 202-208.
[9]	陈学迪, 叶润, 潘卫庆. 中缅边境及泰国东南地区恶性疟原虫K13基因侧翼微卫星多态性研究[J]. 中国寄生虫学与寄生虫病杂志, 2017, 35(3): 209-212.
[10]	周瑞敏, 李素华, 张雅兰, 钱丹, 杨成运, 刘颖, 赵玉玲, 张红卫, 许汴利. 河南省输入性卵形疟原虫2个亚种富色氨酸抗原基因的多态性分析[J]. 中国寄生虫学与寄生虫病杂志, 2017, 35(1): 13-17.
[11]	李美，夏志贵，汤林华*. 检测4种人体疟原虫多重PCR体系的建立和应用[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(2): 3-91-95.
[12]	黄炳成，徐超，李瑾，肖婷，尹昆，刘功振，王卫艳，赵桂华，魏艳彬，王用斌，赵长磊，魏庆宽* . 巢式PCR技术在输入性卵形疟诊断中的应用研究[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(1): 10-49-51.
[13]	周银发，张山鹰*，林耀莹，杨发柱，谢汉国，肖方震. 恶性疟原虫顶端膜抗原1基因多态性分析[J]. 中国寄生虫学与寄生虫病杂志, 2014, 32(5): 4-344-347.
[14]	张玲玲，阮卫，陈华良，陆巧绎，姚立农*. 浙江省5例输入性卵形疟原虫wallikeri亚种感染病例的鉴定[J]. 中国寄生虫学与寄生虫病杂志, 2014, 32(5): 8-361-365.
[15]	吴凯，周水茂，杨燕，王重新，徐明星. 输入性恶性疟原虫Pf60.1基因多态性初步研究[J]. 中国寄生虫学与寄生虫病杂志, 2014, 32(4): 17-318-319.